Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Eryaspase in addition to chemotherapy for treating advanced or metastatic pancreatic cancer – second-line	Eryaspase (Graspa; ERY001) , FOLFOX4 , Gemcitabine (Gemzar; gemcitabine hydrochloride)	Pancreatic cancer	Gastrointestinal Cancer	2020	View \| Download
Erdafitinib for treating advanced solid tumours with an FGFR mutation in people aged 6 years and older	Erdafitinib (JNJ-42756493; BALVERSA)	Solid tumours	Haematological Cancer and Lymphomas , Oncology	2021	View \| Download
Erdafitinib capsules for metastatic or surgically unresectable urothelial cancer with FGFR gene aberrations – second line therapy	Erdafitinib (JNJ-42756493; BALVERSA)	Urothelial cancer	Urological Cancer	2017	View \| Download
ERC1671 (Gliovac) for recurrent grade IV glioma	Bevacizumab (Avastin; R 435; RG 405; RG 435) , ERC1671 (Gliovac)	Glioma	Neurological Cancer	2019	View \| Download
Eptinezumab for prevention of Migraine	Eptinezumab (ALD403)	Migraine	Neurology	2020	View \| Download
Eplontersen for treating transthyretin amyloid cardiomyopathy	Eplontersen (ION-682884;AKCEA TTR-LRx)	Transthyretin amyloid cardiomyopathy	Cardiovascular System	2024	View \| Download
Eplontersen for hereditary transthyretin-mediated amyloid polyneuropathy	Eplontersen (ION-682884;AKCEA TTR-LRx)	Transthyretin-mediated amyloid polyneuropathy	Genetic Disorders	2023	View \| Download
Epcoritamab for treating relapsed or refractory follicular lymphoma	Epcoritamab (GEN-3013)	Follicular lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma previously treated with at least one line of systemic therapy	Epcoritamab (GEN-3013)	B-cell non-Hodgkin lymphoma	Haematological Cancer and Lymphomas	2024	View \| Download
Epcoritamab for diffuse large B-cell lymphoma after two previous treatments	Epcoritamab (GEN-3013)	Diffuse large B-cell lymphoma (DLBCL)	Haematological Cancer and Lymphomas	2021	View \| Download